Cargando…
FXR Agonist INT-747 Upregulates DDAH Expression and Enhances Insulin Sensitivity in High-Salt Fed Dahl Rats
AIMS: Genetic and pharmacological studies have shown that impairment of the nitric oxide (NO) synthase (NOS) pathway is associated with hypertension and insulin-resistance (IR). In addition, inhibition of NOS by the endogenous inhibitor, asymmetric dimethylarginine (ADMA), may also result in hyperte...
Autores principales: | Ghebremariam, Yohannes T., Yamada, Keisuke, Lee, Jerry C., Johnson, Christine L. C., Atzler, Dorothee, Anderssohn, Maike, Agrawal, Rani, Higgins, John P., Patterson, Andrew J., Böger, Rainer H., Cooke, John P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3617194/ https://www.ncbi.nlm.nih.gov/pubmed/23593273 http://dx.doi.org/10.1371/journal.pone.0060653 |
Ejemplares similares
-
Modulating DDAH/NOS Pathway to Discover Vasoprotective Insulin Sensitizers
por: Lai, Li, et al.
Publicado: (2016) -
Impact of High Salt Independent of Blood Pressure on PRMT/ADMA/DDAH Pathway in the Aorta of Dahl Salt-Sensitive Rats
por: Cao, Yu, et al.
Publicado: (2013) -
Association of Variability in the DDAH1, DDAH2, AGXT2 and PRMT1 Genes with Circulating ADMA Concentration in Human Whole Blood
por: Hannemann, Juliane, et al.
Publicado: (2022) -
Upregulation of DDAH2 Limits Pulmonary Hypertension and Right Ventricular Hypertrophy During Chronic Hypoxia in Ddah1 Knockout Mice
por: Hannemann, Juliane, et al.
Publicado: (2020) -
Assessment of DDAH1 and DDAH2 Contributions to Psychiatric Disorders via In Silico Methods
por: Kozlova, Alena A., et al.
Publicado: (2022)